Polyminerol® (Solution) Instructions for Use
Marketing Authorization Holder
Lavena, AD (Bulgaria)
ATC Code
A01AD11 (Other drugs)
Dosage Form
| Polyminerol® | Solution for topical use: bottle 100 ml |
Dosage Form, Packaging, and Composition
Solution for topical use opalescent, yellow in color, with a faint thymol-menthol odor.
| 100 ml | |
| Mother liquor of Pomorie Lake | 128.416 g |
Excipients: sodium saccharin, ethanol, menthol, thymol.
100 ml – dark glass bottles (1) – cardboard boxes.
Clinical-Pharmacological Group
Drug used for periodontal diseases and gingivitis
Pharmacotherapeutic Group
Topical anti-inflammatory agent
Pharmacological Action
Polyminerol® is a combined preparation of natural origin for topical use in dentistry. The action of the drug is due to the properties of the components that make up the Pomorie Lake lye (macro- and microelements, their salts, colloidal substances).
The drug has a local anti-inflammatory effect, reduces the permeability of blood vessels, stimulates phagocytosis, improves tissue regeneration, and has a local analgesic effect.
Pharmacokinetics
Data on the pharmacokinetics of Polyminerol® are not available.
Indications
- Initial and progressive stages of periodontopathy;
- Gingivitis;
- Periodontal disease;
- Gingivostomatitis;
- For the prevention of gum diseases.
The drug is most effective in gum diseases accompanied by bleeding.
ICD codes
| ICD-10 code | Indication |
| K05 | Gingivitis and periodontal diseases |
| K12 | Stomatitis and related lesions |
| ICD-11 code | Indication |
| DA01.Z | Diseases of the oral mucosa, unspecified |
| DA0B.Z | Gingival diseases, unspecified |
| DA0C.Z | Periodontal diseases, unspecified |
| DA0Z | Diseases or disorders of the orofacial complex, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
The drug is intended for topical use.
Treatment of catarrhal, ulcerative, hypertrophic gingivitis, and the initial phase of treatment of periodontal disease should be carried out by a dentist. Treatment should begin with the removal of tartar, as well as the elimination of all possible causes of gum irritation. Before each therapy session with Polyminerol®, the interdental spaces and gum pockets should be cleaned.
Prevention of gum diseases is carried out by the patient himself by rinsing the mouth with a diluted solution (1:4) for 5 minutes 1-2 times/day.
For catarrhal gingivitis, it is recommended to rinse the mouth with a diluted solution of Polyminerol® (1 part of the drug to 4-5 parts of water) at least 3 times/day for 10 minutes. After using the drug, you should not rinse your mouth with water. If this therapy is ineffective, it is recommended to apply dressings with undiluted Polyminerol® mixed with fletcher (a paste for a temporary dressing): mix fletcher with Polyminerol® and knead to the consistency of a soft dough. The mixture of Polyminerol® and fletcher is applied to gauze strips, which are applied to the gums with the gauze facing outward. The dressing hardens after a few minutes and is kept for 2-3 hours to a day. The patient can remove the dressing himself.
For ulcerative and hypertrophic gingivitis, treatment begins with the application of dressings, with cotton swabs soaked in Polyminerol® placed in the interdental spaces, and loose cotton drains placed in the gum pockets. Dressings are applied every other day. Additionally, you should rinse your mouth daily with a diluted solution of Polyminerol®.
For periodontal disease in the initial phase, dressings with Polyminerol® are used in combination with drains in the interdental spaces and rinsing the mouth with a diluted solution of Polyminerol®.
For periodontal disease in the progressive stage in the presence of gum pockets, cotton drains soaked in the drug are deeply inserted into the bottom of the pocket using a probe; initially, they should be changed 2-3 times every 5 minutes, and a dressing is applied to the gum. Only drains or only dressings can be used, but their combination gives a faster effect. Rinsing the mouth should always accompany the use of dressings and drains.
The course of treatment consists of 10-15 dressings. Dressings are applied every other day, the last 4-5 procedures – 2 times a week. If the treatment consists only of drains, at the beginning of therapy they are done every day, and then after 20-30 days.
Adverse Reactions
With tight application of tampons, subfebrile temperature is possible, due to impaired outflow of purulent exudate, which disappears on its own after removal of the tampons.
Contraindications
- Hypersensitivity to the components of the drug.
Use in Pregnancy and Lactation
The drug can be used during pregnancy and lactation (breastfeeding).
Special Precautions
During treatment, a soft toothbrush should be used and the oral cavity should be cleaned carefully. The use of Pomorin toothpaste and the intake of high-calorie and vitamin-rich food are recommended. Additionally, it is recommended to take vitamins A, B1, C, D, E. Active treatment of concomitant diseases is necessary, especially if they are associated with gum disease (diabetes mellitus, peptic ulcer, gastritis, neurasthenia).
If necessary, Polyminerol® can be used in combination with other drugs, for example, antibiotics, in the treatment of progressive forms of periodontal disease or in severe cases of ulcerative stomatitis.
The result of treatment will be more stable if the patient rinses the mouth with a diluted solution of Polyminerol® for a long period of time after the end of therapy. Rinsing is also indicated for prevention in case of predisposition to gum diseases.
Overdose
Cases of overdose with Polyminerol® have not been reported to date.
Drug Interactions
Drug interactions of Polyminerol® have not been established.
Storage Conditions
The drug should be stored at a temperature from 15°C (59°F) to 30°C (86°F).
Shelf Life
Shelf life – 3 years.
Dispensing Status
The drug is approved for use as an over-the-counter product.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer